𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The predictors of response to neoadjuvant chemotherapy in advanced epithelial ovarian cancer

✍ Scribed by Yusuf Yildirim; Ibrahim Egemen Ertas; Askin Dogan; Ozge Elmastas Gultekin; Emre Gultekin

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
178 KB
Volume
105
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hormonal receptors in locally advanced b
Hormonal receptors in locally advanced breast cancer: Change with response to neoadjuvant chemotherapy?
✍ Don M. Morris; Jackie Edwards; Frank Gelder πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 1 views

## Abstract Twenty‐one cancers in 20 patients with locally advanced breast cancer were studied. Incisional biopsy was performed without using electrocautery. Tissue was obtained for histology and estrogen (ER) and progesterone (PR) receptors. Patients received chemotherapy after biopsy. All respond

p16INK4a expression in cytology of ascit
p16INK4a expression in cytology of ascites and response to chemotherapy in advanced ovarian cancer
✍ Tomoko Goto; Masashi Takano; Junko Hirata; Toshiyuki Kohno; Shigenori Ohtsuka; K πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 313 KB

## Abstract The aim of this study is to investigate p16INK4a expression by immunocytochemistry for ascites in advanced ovarian cancer and explore the possibility to predict chemotherapeutic response and prognosis. The immunocytochemical study was performed on cytology of ascites obtained from 37 St

Serum soluble Fas levels and prediction
Serum soluble Fas levels and prediction of response to platinum-based chemotherapy in epithelial ovarian cancer
✍ Parvesh Chaudhry; Radhika Srinivasan; Firuza D Patel; Sarala Gopalan; Siddhartha πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 199 KB πŸ‘ 1 views

## Abstract Epithelial ovarian cancer (EOC) is treated mainly by platinum‐based combination chemotherapy. Chemotherapy induces apoptosis in which the Fas/Fas ligand pathway is important. Serum soluble Fas (sFas) is a biomarker of this pathway and functionally inhibits Fas‐/FasL‐mediated apoptosis.